Studies have shown that the peptide demonstrates approximately 40% oral bioavailability in animal models and exhibits rapid metabolism with a serum half-life of approximately 4 minutes, though its metabolic effects persist significantly longer due to downstream cellular activation
Intranasal Peptide Delivery Explained
Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer
Individual responses vary, life interferes with schedules, and side effects sometimes demand adjustments
Peptydy nowa klasa lekw przeciwnowotworowych[Peptides: a new class of anticancer drugs]
Long-term use should be approached cautiously because some patients report mild side effects like nausea or injection site discomfort, and research on prolonged use is limited. To minimize the risk of adverse reactions, always get the injections from a registered physician
